Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues:
Products, net	$ 359,484	$ 231,495
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember
Collaboration and other	$ 53,980	$ 22,005
Total revenues	413,464	253,500
Cost and expenses:
Cost of sales (excluding amortization of in-licensed rights)	50,559	35,017
Research and development	200,396	245,679
Selling, general and administrative	127,003	110,714
Amortization of in-licensed rights	601	178
Total cost and expenses	378,559	391,588
Operating income (loss)	34,905	(138,088)
Other income (loss), net:
Loss on debt extinguishment	0	(387,329)
Other income, net	6,543	12,707
Total other income (loss), net	6,543	(374,622)
Income (loss) before income tax expense	41,448	(512,710)
Provision for Income tax	5,329	4,045
Net income (loss)	36,119	(516,755)
Other comprehensive income (loss):
Unrealized gains (losses) on investments, net of tax	(1,609)	1,245
Total other comprehensive (loss) income	(1,609)	1,245
Comprehensive income (loss)	$ 34,510	$ (515,510)
Earnings (loss) per share:
Earnings (loss) per common share, basic	$ 0.38	$ (5.86)
Earnings (loss) per common share, diluted	$ 0.37	$ (5.86)
Weighted average number of shares of common stock used in computing earnings (loss) per share
Basic	93,991,000	88,186,000
Diluted	99,114,000	88,186,000